KANNALIFE SCIENCES, INC.
West Hills, NY · Founded 2010 · CIK 0001538856 · Biotech · Public
KLS-13019, a cannabidiol analogue molecule for treating chemotherapy-induced peripheral neuropathy
kannalife.com →- Grants
- $3.3M
- 4 awards
- Sector median: 1
- Raised
- $1.5M
- 2 Form D · Apr 2013
- 161 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 1 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2011201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $15,000,000 | |
| Private capital raised | Form D · SEC | $1,500,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of KLS-13019 for Chemotherapy Induced Peripheral Neuropathy and Drug Dependence | $299,916 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of KLS-13019 for Neuropathic Pain | $977,054 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of KLS-13019 for Neuropathic Pain | $991,944 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of KLS-13019 for Neuropathic Pain | $1,001,774 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2149 | EpiBiologics, Inc. | — | $30M |
| 2150 | Egalet Corp | — | $42M |
| 2151 | Denali Medical II, Inc. | — | $4.0M |
| 2152 | KANNALIFE SCIENCES, INC. | — | $1.5M |
| 2153 | QRKANSWER LLC | — | — |
| 2154 | Valeo Pharma Inc. | — | $787K |
| 2155 | Falcon Therapeutics, Inc. | — | $700K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Mark CorraoExecutive Officer
- W. DrehkoffDirector · Executive Officer
- Thoma KikisDirector · Executive Officer
- Thomas KikisDirector · Executive Officer
- Michael Mona, Jr.Director
- Ramesh PandeyDirector · Executive Officer
- Dean PetkanasDirector · Executive Officer
- Stuart TitusDirector
Patents
- Functionalized 1,3-BENZENE Diols And Their Method Of Use For The Treatment Of Inflammation And Painapplication
- Functionalized 1,3-BENZENE Diols And Their Method Of Use For The Treatment Of Radiation Dermatitis And Other Skin Disordersapplication
- Use Of Certain Phosphatidylcholines Containing Long Chain Polyunsaturated Fatty Acids As Neuroprotective Agentsapplication
- Method For Treating Hepatic Encephalopathy Or A Disease Associated With Free Radical Mediate Stress And Oxidative Stress With Novel Functionalized 1,3-BENZENE Diolsgranted
- Functionalized 1,3-BENZENE Diols And Their Method Of Use For The Treatment Of Radiation Dermatitis And Other Skin Disordersapplication
- Use Of Certain Phosphatidylcholines Containing Long Chain Polyunsaturated Fatty Acids As Neuroprotective Agentsapplication
- Functionalized 1,3-BENZENE Diols And Their Method Of Use For The Treatment Of Radiation Dermatitis And Other Skin Disordersapplication
- Use Of Certain Phosphatidylcholines Containing Long Chain Polyunsaturated Fatty Acids As Neuroprotective Agentsapplication
- Functionalized 1,3-BENZENE Diols And Their Method Of Use For The Treatment Of Inflammation And Painapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.